Investigating Gram-negative bacilli isolates’ sensitivity to ceftazidime/avibactam
Background: Multidrug resistant (MDR) Gram negative organisms are becoming increasingly common. Carbapenem resistant Enterobacterales (CRE) pose a major threat and necessitate the development of new antibiotics. MDR and carbapenem resistant infections, which are common in intensive care units and ho...
Saved in:
Main Authors: | Sunali, Mithilesh Kumar Jha, Mukesh Kumar, Maneesh Kumar, Nishant Ranjan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jfmpc.jfmpc_1272_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of ceftazidime-avibactam with or without polymyxin for carbapenem-resistant Klebsiella pneumoniae infections after initial treatment with polymyxin
by: Jingli Lu, et al.
Published: (2025-01-01) -
Ceftazidime-Avibactam Versus Colistin for the Treatment of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infections: A Multicenter Cohort Study
by: Thamer A. Almangour, et al.
Published: (2025-01-01) -
Profile of outer membrane proteins of carbapenem-resistant Gram-negative bacilli in Ghana
by: Francis S. Codjoe, et al.
Published: (2025-02-01) -
Ceftazidime–avibactam for the Treatment of Intra-abdominal Sepsis and Urosepsis: A Retrospective Hospital-based Study in India
by: Prachee Sathe, et al.
Published: (2024-12-01) -
Mortality-related risk factors of carbapenem-resistant Enterobacteriaceae infection with focus on antimicrobial regimens optimization: a real-world retrospective study in China
by: Sheng Deng, et al.
Published: (2025-01-01)